Help
Options
Didn't know it?
click below
click below
Knew it?
click below
click below
Don't Know
Remaining cards (0)
Know
retry
shuffle
restart
0:00
Embed Code - If you would like this activity on your web page, copy the script below and paste it into your web page.
Normal Size Small Size show me how
Normal Size Small Size show me how
PHAR 517
Chemotherapy - drug class
| Term | Definition |
|---|---|
| methotrexate | antimetabolite (antifolate) |
| pemetrexed | antimetabolite (antifolate) |
| 5-FU | antimetabolite (antipyrimidine) |
| capecitabine | antimetabolite (antipyrimidine) |
| cytarabine (Ara-c) | antimetabolite (antipyrimidiine) |
| gemcitabine | antimetabolite (antipyrimidine) |
| 6-MP - mercaptopurine | antimetabolite (antipurine) |
| fludarabine | antimetabolite (antipurine) |
| cladribine | antimetabolite (antipurine) |
| clofarabine | antimetabolite (antipurine) |
| hydroxyurea | antimetabolite |
| vincristine | antimicrotubule (vinca alkaloid) |
| vinblastine | antimicrotubule (vinca alkaloid) |
| vinorelbine | antimicrotubule (vinca alkaloid) |
| paclitaxel | antimicrotubule (taxanes) |
| nab-paclitaxel | antimicrotubule (taxanes) |
| docetaxel | antimicrotubule (taxanes) |
| irinotecan | topoisomerase I inhibitor |
| topotecan | topoisomerase I inhibitor |
| etoposide | topoisomerase II inhibitor |
| bleomycin | misc |
| L-asparaginase | misc |
| peg-asparaginase | misc |
| Erwinia-asparaginase | misc |
| everolimus | mTOR inhibitor |
| temsirolimus | mTOR inhibitor |
| chlorambucil | alkylating agent (nitrogen mustard) |
| cyclophosphamide | alkylating agent (nitrogen mustard) |
| ifosfamide | alkylating agent (nitrogen mustard) |
| bendamustine | alkylating agent (nitrogen mustard) |
| dacarbazine | alkylating agent (nitrogen mustard) |
| cisplatin | alkylating agent (platinum) |
| carboplatin | alkylating agent (platinum) |
| oxaliplatin | alkylating agent (platinum) |
| decitabine | alkylating agent (hypomethylating agent) |
| daurorubicin | anthracycline |
| doxorubicin | anthracycline |
| idarubicin | anthracycline |
| epirubicin | anthracycline |
| rituximab | mAB - CD20 (chimeric) |
| trastuzumab | mAB - HER-2 (humanized) |
| pertuzumab | mAB - HER-2 (humanized) |
| cetuximab | mAB - EGFR (chimeric) |
| bevacizumab | mAB - VEGF ligand (humanized) |
| pembrolizumab | mAB - PD-1 receptor (humanized) |
| nivolumab | mAB - PD-1 receptor (human) |
| cemiplimab | mAB - PD-1 receptor (human) |
| dostarlimab | mAB - PD-1 receptor (human) |
| atezolizumab | mAB - PD-L1 ligand (humanized) |
| durvalumab | mAB - PD-L1 ligand (human) |
| avelumab | mAB - PD-L1 (human) |
| imatinib | tyrosine kinase inhibitor (BCR-ABL) |
| desatinib | tyrosine kinase inhibitor (BCR-ABL) |
| nilotinib | tyrosine kinase inhibitor (BCR-ABL) |
| bosutinib | tyrosine kinase inhibitor (BCR-ABL) |
| ponatinib | tyrosine kinase inhibitor (BCR-ABL) |
| erlotinib | tyrosine kinase inhibitor (EGFR) |
| osimertinib | tyrosine kinase inhibitor (EGFR) |
| alectinib | tyrosine kinase inhibitor (ALK) |
| brigatinib | tyrosine kinase inhibitor (ALK) |
| lorlatinib | tyrosine kinase inhibitor (ALK) |
| dabrafenib | tyrosine kinase inhibitor (BRAF) |
| olaparib | PARP inhibitor |
| niraparib | PARP inhibitor |
| talazoparib | PARP inhibitor |
| bortezomib | proteasome inhibitor |
| carfilzomib | proteasome inhibitor |
| thalidomide | immunomodulator |
| lenalidomide | immunomodulator |
Created by:
amarquez539
Popular Pharmacology sets